Abstract:Objective To study the expression of estrogen receptor α,β in different breast tissues and the relation with breast cancer. Methods The expressions of Erα、Erβ were detected in 202 patients' samples by immunohistochemistry. The specimens were divided into normal mammary glands( 15 cases), benign hyperplasia of mammary glands( 35 cases), atypical hyperplasia of mammary glands(12 cases) and breast cancers(155 cases). Results The positive rates of Erα in normal mammary glands, benign hyperplasia of mammary glands, atypical hyperplasia of mammary glands and breast cancers were 46. 6% , 54. 3% , 58. 3% , 68. 4% respectively. The positive rates of Erβ were 93. 3% , 88. 6% , 75% and 42.6% respectively; Erα had no statistically significant difference between normal and malignancy mammary glands(P 0.05); the positive rate of Erβ in normal mammary glands was significantly higher than that in breast cancers(P 0.001); the positive rate of Erα in normal mammary glands was significantly lower than that of Erβ( P 0.05); and the positive rate of Erα in malignancy mammary glands was significantly higher than that of Erβ( F 0.001). The expressions of Erα in cases -2 cm,breast cancer with staging I, without lymph node metastasis and without metastasis were significantly higher than those 2 cm, with staging II + III + IV , with lymph node metastasis and with metastasis ( P 0.001、 P0.001、P0.01、P0.05). The expressions of Erβ in cases -2 cm,breast cancer with staging I were significantly higher than those 2 cm and with staging II + IIII + IV(P0.001,P0.01). Conclusion The expression of Erβ is higher in normal mammary glands,Erβ has important impact in occurrence and development of breast cancer; the higher expressions of Erα and Erβ are correlated with the good prognosis of breast cancer, they are both important indexes in the prognosis of breast cancers.

Eukaryotic Expression Vectors Construction and Transcriptional Ac tivity Analysis of Different Isoforms of ERβ in Breast Cancer

Construction of Estrogen Receptor β Eukaryotic Expression Vector and Detection of its Transcription Activity

Construction of Estrogen Receptor Β Expression Vector and Its Transcriptional Activity

Construction of Estrogen Receptor α Eukaryotic Expression Vector and Detection of its Transcription Activity

Construction of ERbeta expression vector and its function in different cancer cells]

Epigenomics-based Identification of Oestrogen-Regulated Long Noncoding RNAs in ER+ Breast Cancer.

The Cloning of the VEGF Promoter Reporter and the Effect of Estrogen Receptor on the Reporter Activity

Establishment of Estrogen Eeceptor β Transcriptional Activation System

Quantitative Profiles of the Mrnas of ER-α and Its Novel Variant ER-α36 in Breast Cancers and Matched Normal Tissues

Lentivirus Mediated Estrogen Receptor β Overexpression Inhibits Epithelial-Mesenchymal Transition Associated Gene Expression in Breast Cancer Cells

The Expression of Estrogen Receptor Α, Β in Different Breast Tissues and Its Relation with Breast Cancer

Construction and Activity Detection of Potent Phosphorylation Sites Mutants of Estrogen Receptor β

Expression and Significance of Estrogen Receptor Isoforms in Different Breast Tissues

Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.

The expressing signification of estrogen receptorβ in breast cancer

[Construction and Expression of Bisbicistronic Expression Vector of Novel Endocrine and Exocrine Protein Gene Associated with Breast Cancer and IRES Mediated Gene EGFP].

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

[Establishment of Estrogen Receptor Alpha Trans-Activation System].

ER β exerts multiple stimulative effects on human breast carcinoma cells

Construction and Expression of Silence Expression Vector for Beta-Estrogen Receptor

ER-α36: a Novel Biomarker and Potential Therapeutic Target in Breast Cancer.